Emily M. Leproust - 18 Jan 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role: President & CEO, Director
Signature: /s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Issuer symbol: TWST
Transactions as of: 18 Jan 2022
Net transactions value: -$59,455
Form type: 4
Filing time: 20 Jan 2022, 15:35:38 UTC
Previous filing: 04 Jan 2022
Next filing: 26 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TWST	Common Stock	Options Exercise	$2,523	+286	+0.14%	$8.82	198,875	18 Jan 2022	Direct
transaction	TWST	Common Stock	Sale	$17,169	-286	-0.14%	$60.03	198,589	18 Jan 2022	Direct	F1, F2
transaction	TWST	Common Stock	Tax liability	$44,809	-579	-0.29%	$77.39	198,010	18 Jan 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TWST	Employee Stock Option (right to buy)	Options Exercise	$0	+286	+0.19%	$0.000000	150,879	18 Jan 2022	Common Stock	286	$8.82	Direct	F5
holding	TWST	Employee Stock Option (right to buy)						24,360	18 Jan 2022	Common Stock	0	$5.95	Direct	F4
holding	TWST	Employee Stock Option (right to buy)						266,539	18 Jan 2022	Common Stock	0	$26.66	Direct	F6
holding	TWST	Employee Stock Option (right to buy)						131,290	18 Jan 2022	Common Stock	0	$23.33	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
F2	Represents the weighted average sales price per share. The shares sold at prices ranging from $60.00 to $60.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3	Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F4	The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5	The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6	20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7	25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.